ACM
ELV icon

Accipiter Capital Management’s Elevance Health ELV Stock Holding History

Accipiter Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-138,728
Closed -$11.6M – 8
2013
Q3 		$11.6M Sell
138,728
-75,463
-35% -$6.47M 10.66% 3
2013
Q2 		$17.5M Buy
+214,191
New +$16M 13.76% 2

Other funds holding ELV

Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Accipiter Capital Management's ELV Position: Q4 2013 in Review

Accipiter Capital Management sold out of Elevance Health (ELV) in Q4 2013, closing a stake of 138,728 shares — an estimated $11.6M sold.

Accipiter Capital Management first reported a position in ELV in Q2 2013 and held it in 2 quarters. The position peaked at $17.5M in Q2 2013. 640 funds tracked by Wall St. Rank hold ELV as of Q4 2013.

  • Accipiter Capital Management reported no remaining Elevance Health position as of Q4 2013 after selling out during the quarter.
  • Accipiter Capital Management sold 138,728 Elevance Health shares in Q4 2013, an estimated $11.6M.
  • Accipiter Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 2 quarters.
  • Accipiter Capital Management's Elevance Health position peaked at $17.5M in Q2 2013.
  • 640 funds tracked by Wall St. Rank held Elevance Health as of Q4 2013.

Based on Accipiter Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.